Far East shoe imports up 21%

Shoe sales to the local market produced by Israeli manufacturers are expected to grow by 7% this year generating $135m.

By SHARON WROBEL
November 12, 2007 08:19

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Imports of shoes from the Far East, including China, Hong Kong, India and Taiwan, rose by 21% to 25 million pairs of shoes generating a volume of $141.6 million in the first nine months of the year, compared with the same period last year. The Manufacturers Association of Israel reported Sunday that in the first three quarters, some 20 million pairs of shoes valued at $88.5m. were imported from China, representing an increase of 15%. Shoe sales to the local market produced by Israeli manufacturers are expected to grow by 7% this year generating $135m. In 2006, shoe sales to the local market increased by 16% to $126m. from the previous year.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS